Details
Study Summary
FDA is using these findings, in addition to input received from the 2014 FDA Public Meeting, to evaluate safety data collection in pregnant women
Related Publication(s) and/or Presentation(s) (3)
Publication: 2016 ICPE Abstract
Publication: Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer’s Capture of Spontaneous Reports for Exposed Pregnancies
Publication: Utilization of Drugs with Pregnancy Exposure Registries During Pregnancy